Skip to content

Transversus Abdominis Muscle Release Versus Mesh Only Repair in the Treatment of Complex Ventral Wall Hernia

Posterior Component Separation With Transversus Abdominis Muscle Release Versus Mesh Only Repair in the Treatment of Complex Ventral Wall Hernia: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04516031
Enrollment
59
Registered
2020-08-17
Start date
2018-08-01
Completion date
2021-01-01
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Abdominal, Hernia Incisional, Hernia, Ventral

Brief summary

This trial was designed as a prospective randomized, controlled, intervention, with two parallel groups, and a primary endpoint of recurrence during 12 months' follow-up after initial treatment, with the randomization, was performed by an online software a 1:1 allocation.

Detailed description

Eligibility Criteria * both sexes * aged between 18 and 65 years old * presented complex ventral wall hernia or incisional hernia Exclusion * pregnant * patients on steroid therapy * underwent their hernia repair on an emergency basis Interventions * Eligible patients were randomized in equal proportions between Mesh Only Repair and Posterior Component Separation with Transversus Abdominis Muscle Release

Interventions

PROCEDUREPosterior Component Separation with Transversus Abdominis Muscle Release

The posterior component separation technique with transversus abdominis muscle release was done as prescribed in Novitsky et al in 2012.

PROCEDUREMesh-only repair

The prosthetic mesh only repair was done as described by Wantz in 1991.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients with complex ventral-wall and incisional hernia

Exclusion criteria

* pregnant female * steroid therapy * emergency basis

Design outcomes

Primary

MeasureTime frameDescription
Hernia recurrenceafter 12 monthsReappearance of symptoms or swelling

Secondary

MeasureTime frameDescription
Morbidity30 days postoperativepostoperative morbidity
Mortality30 days postoperativePostoperative mortality

Countries

Egypt

Contacts

Primary ContactMostafa shalaby, MD, MSc, PhD
mostafashalaby@mans.edu.eg00201001645917

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026